Evidence map›Paper›PMID 42278367›Full record

ArticleInternational journal of molecular sciences2026

Association of Genetic Variants in

Simona Jurkovic Mlakar, Aleksandra Klisic, Janja Marc, Barbara Ostanek

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Simona Jurkovic MlakarDepartment of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0009-0000-9354-6376
Aleksandra KlisicFaculty of Medicine, University of Montenegro, 81000 Podgorica, Montenegro.ORCID 0000-0001-7870-0996
Janja MarcDepartment of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
Barbara OstanekDepartment of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0001-7158-8241

Funding

Central European Exchange Program for University Studies M-SI-0611-2324-177307Ministry of Science 01-082/22-1681/3The Slovenian Research and Innovation Agency P3-0298, J3-4527, BI-ME/23-24-030
6 · The paper itself

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized during adolescence and exhibits sex-specific characteristics. Its prevalence in late adolescent females is around 10% in the general population and exceeds 30% in obesity. Genetic variants in

Indexed as

AcyltransferasesInflammationLipaseMembrane ProteinsNon-alcoholic Fatty Liver DiseaseAdolescentAllelesCross-Sectional StudiesFemaleGenetic Predisposition to DiseaseGenetic VariationGenotypeHumansPhospholipases A2, Calcium-IndependentPolymorphism, Single NucleotideYoung AdultAcyltransferasesLipaseMembrane ProteinsPhospholipases A2, Calcium-IndependentPNPLA3 protein, humanadolescenceMARC1MASLDMBOAT7metabolic inflammationPNPLA3SIITyG

Identifiers

PMID42278367
PMCPMC13256969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.